公开(公告)号：EP3922251A1

公开(公告)日：2021-12-15

申请号：EP20798403.0

申请日：2020-04-23

申请人： Industry-Academic Cooperation Foundation, Yonsei University ,  CURACLE Co., Ltd.

发明人： KWON, Young-Guen ,  ZHANG, Haiying ,  PARK, Songyi ,  NOH, Minyoung ,  KIM, Yeomyeong ,  KIM, Myung-Hwa ,  AHN, Koo Hyeon ,  PYO, Jung-In

IPC分类号： A61K31/56 ,  A61K31/704 ,  A61K45/06 ,  A61P35/00

摘要： The present invention relates to a cancer immunotherapy adjuvant, wherein the adjuvant, when administered in combination with a cancer immunotherapy agent, activates the function of immune factors without causing in vivo side effects, to exhibit the effect of enhancing the kit for anticancer effect of the cancer immunotherapy agent, and thus can be effectively used as a cancer immunotherapy adjuvant.